• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAROLINA BIOLOGICAL SUPPLY CO. MEDICINAL LEECH; EUROPEAN MEDICINAL LEECH, HIRUDO VERBANA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAROLINA BIOLOGICAL SUPPLY CO. MEDICINAL LEECH; EUROPEAN MEDICINAL LEECH, HIRUDO VERBANA Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Post Operative Wound Infection (2446)
Event Date 11/06/2015
Event Type  Injury  
Manufacturer Narrative
To date we have been unable to confirm any details of this reported event, including whether the leeches involved were supplied by carolina biological supply, the nature of the injuries alleged, and treatment.Attempts to obtain add'l info from the health care facility responsible for the voluntary event are ongoing.Any appropriate info obtained will be communicated to fda in a f/u report.Aeromonas hydrophila infections are a well-known risk associated with leech treatment, thus the details conveyed in the voluntary event report do not suggest an unanticipated adverse event.A.Hydrophila is an endosymbiotic bacterium that is a normal part of the leech gut flora, and medical practitioners often place their pts on antibiotics prior to starting leech therapy as a precautionary measure.It is also known that some hospitals may receive leeches that contain antibiotic resistant a.Hydrophila.The voluntary event report alleges initial prophylactic administration of levaquin, which is not one of the antibiotics recommended in the product instructions.
 
Event Description
Per medwatch report mw5057729, a pt was treated with medicinal leeches with concurrent prophylactic administration of levaquin and subsequently became febrile.Blood culture revealed aeromonas infection resistant to ciprofloxacin, bactrim, and augmentin, but susceptible to ceftriaxone.Levaquin was stopped and ceftriaxone started.Attempts to obtain add'l info from the health care facility responsible for the voluntary event report are ongoing.Any appropriate info obtained will be communicated to fda in a f/u report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDICINAL LEECH
Type of Device
EUROPEAN MEDICINAL LEECH, HIRUDO VERBANA
Manufacturer (Section D)
CAROLINA BIOLOGICAL SUPPLY CO.
2700 york rd.
burlington NC 27215
Manufacturer (Section G)
CAROLINA BIOLOGICAL SUPPLY CO.
2700 york rd.
burlington NC 27215
Manufacturer Contact
keith barker
2700 york rd.
burlington, NC 27215
3363586377
MDR Report Key5376476
MDR Text Key36394087
Report Number1048439-2016-00001
Device Sequence Number1
Product Code NRN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K140907
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Other
Type of Report Initial
Report Date 01/14/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/14/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No Information
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/15/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-